Assessing signal loss, accuracy, and acceptability of an ambulatory fetal electrocardiography with cardiotocography in the antepartum and intrapartum phases
NIFECG has comparable accuracy to CTG for FHR and UC monitoring during the antepartum and intrapartum phases and is well-accepted by women and nurses. Given that 41.1% of NIFECG traces were rejected due to signal loss, further research on improving the technology to reduce signal loss, and re-evaluating the criteria for rejecting traces is vital to achieve broader clinical implementation of NIFECG.
Authors
- Chee Wai Ku
- Jerry Kok Yen Chan (ORCID: https://orcid.org/0000-0002-0246-2159)
- See Ling Loy (ORCID: https://orcid.org/0000-0002-9205-5580)
- R. Sultana
- Michelle Mei Ying Tiong
- Devendra Kanagalingam
- Kirsten Jie Ying Ong
- Meng-Hee Tan
- Chuyen Luong
- Serene Thain
Institutions
- National University of Singapore (SG)
- Singapore General Hospital (SG)
- Biotronik (Singapore) (SG)
- KK Women's and Children's Hospital (SG)
- Duke-NUS Medical School (SG)
Publication Details
- Journal
- Acta Obstetricia Et Gynecologica Scandinavica
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1111/aogs.70113
- Primary Topic
- Neonatal and fetal brain pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Lien Foundation
- Medical Research Council
- National Medical Research Council